Going for baroque at the Escherichia coli K1 cell surface

Trends in Microbiology

Volumn 15, Issue 5, 2007, Pages 196-202

  King, Michael R ^a   Steenbergen, Susan M ^a   Vimr, Eric R ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; POLYSIALIC ACID;

ARTICLE; BACTERIAL CELL; BACTERIAL GENE; CELL SURFACE; ESCHERICHIA COLI; ESCHERICHIA COLI K 1; EVOLUTION; GENE LOCUS; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION;

ACETYLTRANSFERASES; BACTERIAL CAPSULES; ESCHERICHIA COLI; MOLECULAR STRUCTURE; SIALIC ACIDS;

ESCHERICHIA COLI;

EID: 34247543497     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2007.03.006     Document Type: Article

References (52)

1. Sharon N. Complex Carbohydrates: Their Chemistry, Biosynthesis, and Functions (1975), Addison-Wesley Publishing Company
2. Laine R.A. The information-storing potential of the sugar code. In: Gabius H.-J., and Gabius S. (Eds). Glycosciences: Status and Perspectives (1997), Chapman & Hall 1-14
3. 12 structures for a reducing hexasaccharide: the isomer barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 4 (1994) 1-9
4. Vimr E.R., et al. Diversity of microbial sialic acid metabolism. Microbiol. Mol. Biol. Rev. 68 (2004) 132-153
5. Bruses J.L., and Rutishauser U. Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie 83 (2001) 635-643
6. Cheung I.Y., et al. Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma. Int. J. Cancer 119 (2006) 152-156
7. Ragupathi G., et al. Antibody inducing polyvalent cancer vaccines. Cancer Treat. Res. 123 (2005) 157-180
8. Bonfanti L. PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog. Neurobiol. 80 (2006) 129-164
9. El Maarouf A., et al. Use of polysialic acid in repair of the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16989-16994
10. Stein D.M., et al. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?. Vaccine 24 (2006) 221-228
11. Levin B.R., and Bull J.J. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 2 (1994) 76-81
12. Russo T.A., and Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5 (2003) 449-456
13. Moulin-Schouleur M., et al. Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. J. Clin. Microbiol. 44 (2006) 3484-3492
14. Nelson A.L., et al. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 75 (2006) 83-90
15. Vimr E.R., and Steenbergen S.M. Targeting microbial sialic acid metabolism for new drug development. In: Bewley C.A. (Ed). Protein-Carbohydrate Interactions in Infectious Diseases (2006), RSC Publishing 125-150
16. Deszo E.L., et al. Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5564-5569
17. Steenbergen S.M., et al. Separate pathways for O acetylation of polymeric and monomeric sialic acids and identification of sialyl O-acetyl esterase in Escherichia coli K1. J. Bacteriol. 188 (2006) 6195-6206
18. Vimr E.R., and Steenbergen S.M. Mobile contingency locus controlling Escherichia coli K1 polysialic acid capsule acetylation. Mol. Microbiol. 60 (2006) 828-837
19. Lewis A.L., et al. Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11123-11128
20. Lewis A.L., et al. The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters. J. Biol. Chem. 281 (2006) 11186-11192
21. Ørskov F., et al. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J. Exp. Med. 149 (1979) 669-685
22. Higa H.H., and Varki A. Acetyl-coenzyme A:polysialic acid O-acetyltransferase from K1-positive Escherichia coli. J. Biol. Chem. 263 (1988) 8872-8878
23. Kamerling J.P., et al. Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur. J. Biochem. 162 (1987) 601-607
24. van Lenthe J.H., et al. Ab initio calculations on various sialic acids provide valuable information about sialic acid-specific enzymes. J. Mol. Structure: THEOCHEM 677 (2004) 29-37
25. Johnson C.P., et al. Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion. J. Biol. Chem. 280 (2005) 137-145
26. Zhang Y., and Lee Y.C. Acid-catalyzed lactonization of α2,8-linked oligo/polysialic acids studied by high performance anion-exchange chromatography. J. Biol. Chem. 274 (1999) 6183-6189
27. Henderson T.J., et al. Conformational flexibility of the group B meningococcal polysaccharide in solution. J. Am. Chem. Soc. 125 (2003) 2930-2939
28. Shimoda Y., et al. Calcium ion binding of three different types of oligo/polysialic acids as studied by equilibrium dialysis and circular dichroic methods. Biochemistry 33 (1994) 1202-1208
29. Telang S., et al. Strain-specific iron-dependent virulence in Escherichia coli. J. Infect. Dis. 184 (2001) 159-165
30. Sukumaran S.K., et al. Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect. Immun. 71 (2003) 5951-5961
31. Xie Y., et al. Identification and characterization of Escherichia coli RS218-derived islands in the pathogenesis of E. coli meningitis. J. Infect. Dis. 194 (2006) 358-364
32. Kim B.Y., et al. Invasion processes of pathogenic Escherichia coli. Int. J. Med. Microbiol. 295 (2005) 463-470
33. Wooster D.G., et al. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 117 (2006) 482-493
34. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
35. Peshel A., and Sahl H.-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4 (2006) 529-536
36. Campos M.A., et al. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72 (2004) 7107-7114
37. Nogales J., et al. Sinorhizobium meliloti genes involved in tolerance to the antimicrobial peptide protamine. FEMS Microbiol. Lett. 264 (2006) 160-167
38. Locke J.B., et al. Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J. Bacteriol. 189 (2006) 1279-1287
39. Dorschner R.A., et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20 (2006) 35-42
40. Kim C., and Kaufmann S.H.E. Defensin: a multifunctional molecule lives up to its versatile name. Trends Microbiol. 14 (2006) 428-431
41. Frasa H., et al. Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains. J. Clin. Microbiol. 31 (1993) 3174-3178
42. Colino J., and Outschoorn I. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection. Microb. Pathog. 27 (1999) 187-196
43. Pelkonen S., et al. Polyacrylamide gel electrophoresis of the capsular polysaccharides of Escherichia coli K1 and other bacteria. J. Bacteriol. 170 (1988) 2646-2653
44. Rohr T.E., and Troy F.A. Structure and biosynthesis of surface polymers containing polysialic acid in Escherichia coli. J. Biol. Chem. 255 (1980) 2332-2342
45. Wolfram Research, Inc. (2005) Mathematica Version 5.2, Champaign, IL (http://www.wolfram.com)
46. Vimr E.R. Selective synthesis and labeling of polysialic acid capsule in Escherichia coli K1. J. Bacteriol. 174 (1992) 6191-6197
47. Scholl D., et al. Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl. Environ. Microbiol. 71 (2005) 4872-4874
48. West N.P., et al. Optimization of virulence functions through glucosylation of Shigella LPS. Science 307 (2005) 1313-1317
49. Moxon R., et al. Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu. Rev. Genet. 40 (2006) 307-333
50. Kubler-Kielb J., et al. O-acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a. Carbohydr. Res. 342 (2006) 643-647
51. Drake J.W. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7160-7164
52. Gudlavalleti S.K., et al. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy. Carbohydr. Res. 341 (2006) 557-562